2022. Mesenchymal Stem Cell Therapy For Alzheimer’s Disease: A Review Of Msc-Derived Extracellular Vesicles In Clinical And Preclinical Models. Journal of Pharmaceutical Negative Results. (Oct. 2022), 11139–11148. DOI:https://doi.org/10.47750/pnr.2022.13.S09.1304.